Advertisement
Screener

IRONWOOD PHARMACEUTICALS, INC. (IRWD) Graph

IRWD Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $113.04M; Cost of revenue (m); Research and development $22.42M; Selling, general and administrative $11.31M.
  • 2026-03-31: Revenue $106.51M; Cost of revenue (m); Research and development $21.94M; Selling, general and administrative $12.03M.
  • 2025-12-31: Revenue $47.71M; Cost of revenue (m); Research and development $21.86M*; Selling, general and administrative $19.29M*.
  • 2025-09-30: Revenue $122.06M; Cost of revenue (m); Research and development $22.47M; Selling, general and administrative $21.91M.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

IRWD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Revenue$113.04MOperating income$79.31MOther income, net$42.00KResearch & development$22.42MSelling, general& administrative$11.31MPre-tax income$73.73MNet income$51.29M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$113.04M(m)$22.42M$11.31M(m)$22.44M$51.29M
2026-03-31$106.51M(m)$21.94M$12.03M(m)$24.40M$40.77M
2025-12-31$47.71M(m)$21.86M*$19.29M*(m)$2.73M*-$2.28M
2025-09-30$122.06M(m)$22.47M$21.91M(m)$27.94M$40.08M
2025-06-30$85.24M(m)$23.37M$16.80M(m)$14.22M$23.60M
2025-03-31$41.14M(m)$27.43M$24.26M(m)$1.11M-$37.39M
2024-12-31$90.55M(m)(m)(m)(m)(m)$2.26M
2024-09-30$91.59M(m)$29.83M$36.11M(m)$13.72M$3.65M
2024-06-30$94.40M(m)$30.39M$36.96M(m)$19.74M-$860.00K
2024-03-31$74.88M(m)$25.82M$37.60M(m)$9.12M-$4.16M
2023-12-31$117.55M(m)(m)(m)(m)(m)-$1.09M
2023-09-30$113.74M(m)$32.98M$36.05M(m)$17.98M$15.32M
2023-06-30$107.38M(m)$34.58M$52.48M(m)$13.26M-$1.06B
2023-03-31$104.06M(m)$12.85M$31.12M$43.96M$20.15M$45.71M
2022-12-31$107.20M(m)(m)(m)(m)(m)$48.87M
2022-09-30$108.64M(m)$11.54M$28.62M$40.16M$19.59M$50.32M
2022-06-30$97.23M(m)$11.45M$30.12M$41.58M$16.70M$37.08M
2022-03-31$97.53M(m)$10.82M$28.86M$39.68M$17.66M$38.80M
2021-12-31$117.13M(m)(m)(m)(m)(m)$41.37M
2021-09-30$103.75M(m)$10.91M$27.74M$38.58M$3.83M$55.84M
2021-06-30$104.03M(m)$12.16M$27.05M$38.93M-$336.93M$391.30M
2021-03-31$88.84M(m)$15.48M$27.65M$43.45M$432.00K$39.93M
2020-12-31$116.68M(m)(m)(m)(m)(m)$43.20M
2020-09-30$103.47M(m)$21.69M$34.93M(m)$1.39M$34.42M
2020-06-30$89.43M(m)$22.08M$34.64M(m)$0.00$25.20M
2020-03-31$79.94M$2.24M$28.03M$36.45M(m)(m)$3.35M
2019-12-31$126.30M(m)(m)(m)(m)(m)$47.86M
2019-09-30$131.17M$506.00K$27.55M$40.92M(m)(m)$20.65M
2019-06-30$102.22M$11.31M$28.76M$43.25M(m)(m)$12.28M
2019-03-31$68.73M$1.04M$32.20M$49.09M(m)(m)-$59.28M
2018-12-31$130.69M(m)(m)(m)(m)(m)-$15.49M
2018-09-30$65.69M$4.62M$29.16M$50.54M(m)(m)-$174.35M
2018-06-30$81.11M$4.07M$23.19M$59.77M(m)(m)-$49.38M
2018-03-31$69.16M$2.61M$36.51M$59.50M(m)(m)-$43.14M
2017-12-31$94.21M(m)(m)(m)(m)(m)$12.09M
2017-09-30$86.83M$6.08M$37.06M$61.77M(m)(m)-$32.30M
2017-06-30$65.08M$3.50M$37.34M$57.79M(m)(m)-$44.22M
2017-03-31$52.17M$531.00K$33.70M$55.60M(m)(m)-$52.50M
2016-12-31$87.46M(m)(m)(m)(m)(m)-$13.51M
2016-09-30$66.11M(m)$37.53M$44.99M(m)(m)-$33.20M
2016-06-30$54.35M(m)$31.68M$36.92M(m)(m)-$21.70M
2016-03-31$66.04M(m)$31.84M$36.17M(m)(m)-$13.30M
2015-12-31$53.31M(m)(m)(m)(m)(m)(m)
2015-09-30$39.57M(m)$25.83M$30.44M(m)(m)(m)
2015-06-30$27.74M$8.15M$28.65M$32.95M(m)(m)(m)
2015-03-31$28.93M$12.00K$26.64M$30.35M(m)(m)(m)
2014-12-31$38.07M(m)(m)(m)(m)(m)(m)
2014-09-30$16.92M(m)$25.12M$28.54M(m)(m)(m)
2014-06-30$6.84M$10.52M$22.14M$29.30M(m)(m)(m)
2014-03-31$14.61M$1.92M$27.14M$29.92M(m)(m)(m)
2013-12-31$5.03M(m)(m)(m)(m)(m)(m)
2013-09-30$4.93M$2.02M$23.02M$30.26M(m)(m)(m)
2013-06-30$9.66M$3.42M$24.09M$30.87M(m)(m)(m)
2013-03-31$3.25M$1.23M$32.75M$33.37M(m)(m)(m)
2012-12-31$26.98M(m)(m)(m)(m)(m)(m)
2012-09-30$96.41M(m)$23.45M$22.85M$48.80M(m)(m)
2012-06-30$14.60M(m)$32.24M$20.10M$55.44M(m)(m)
2012-03-31$12.25M(m)$29.51M$16.32M$47.88M(m)(m)
2011-12-31$32.15M(m)(m)(m)$39.19M(m)(m)
2011-09-30$12.22M(m)$22.91M(m)$33.83M$3.00K(m)
2011-06-30$11.26M(m)$19.41M(m)$30.21M(m)-$18.84M
2011-03-31$10.24M(m)$19.55M(m)$28.78M(m)(m)
2010-12-31$16.77M(m)(m)(m)$29.57M(m)(m)
2010-09-30$9.06M(m)$18.74M(m)$25.22M-$2.94M(m)
2010-06-30$9.19M(m)$19.90M(m)$26.50M(m)-$17.14M
2010-03-31$8.84M(m)(m)(m)$23.33M(m)(m)

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$219.55M(m)$44.36M$23.35M(m)$46.84M$92.06M
2025-06-30$126.38M(m)$50.80M$41.05M(m)$15.34M-$13.79M
2024-06-30$169.27M(m)$56.20M$74.57M(m)$28.86M-$5.02M
2023-06-30$211.44M(m)$47.42M$83.60M(m)$33.40M-$1.02B
2022-06-30$194.76M(m)$22.27M$58.98M$81.26M$34.37M$75.88M
2021-06-30$192.88M(m)$27.65M$54.70M$82.38M-$336.50M$431.23M
2020-06-30$169.38M$2.24M$50.10M$71.09M(m)$0.00$28.55M
2019-06-30$170.94M$12.36M$60.96M$92.34M(m)(m)-$47.00M
2018-06-30$150.26M$6.67M$43.66M$118.72M(m)(m)-$92.52M
2017-06-30$117.24M$4.03M$71.05M$113.40M(m)(m)-$96.72M
2016-06-30$120.39M(m)$63.52M$73.09M(m)(m)-$35.00M
2015-06-30$56.68M$8.16M$55.29M$63.30M(m)(m)(m)
2014-06-30$21.45M$12.44M$49.29M$59.22M(m)(m)(m)
2013-06-30$12.92M$4.65M$56.85M$64.24M(m)(m)(m)
2012-06-30$26.85M(m)$61.75M$36.42M$103.32M(m)(m)
2011-06-30$21.50M(m)$38.96M(m)$58.99M(m)-$37.24M
2010-06-30$18.03M(m)$37.45M(m)$49.83M(m)-$33.06M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$248.44M(m)$73.27M$62.96M(m)$43.28M$26.29M
2024-09-30$260.87M(m)$86.03M$110.68M(m)$42.58M-$1.38M
2023-09-30$325.18M(m)$80.41M$119.65M(m)$51.38M-$1.00B
2022-09-30$303.40M(m)$33.82M$87.60M$121.42M$53.96M$126.20M
2021-09-30$296.62M(m)$38.55M$82.45M$120.96M-$332.67M$487.07M
2020-09-30$272.84M$2.24M$71.80M$106.02M(m)$1.39M$62.97M
2019-09-30$302.11M$12.86M$88.51M$133.26M(m)(m)-$26.35M
2018-09-30$215.95M$11.29M$72.82M$169.25M(m)(m)-$266.88M
2017-09-30$204.07M$10.11M$108.11M$175.17M(m)(m)-$129.02M
2016-09-30$186.50M(m)$101.05M$118.07M(m)(m)-$68.20M
2015-09-30$96.25M$12.00K$81.12M$93.74M(m)(m)(m)
2014-09-30$38.36M$3.55M$74.41M$87.76M(m)(m)(m)
2013-09-30$17.85M$6.67M$79.86M$94.51M(m)(m)(m)
2012-09-30$123.27M(m)$85.20M$59.26M$152.13M(m)(m)
2011-09-30$33.72M(m)$61.87M(m)$92.83M$3.00K(m)
2010-09-30$27.09M(m)$56.19M(m)$75.06M-$2.94M(m)

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$296.15M(m)$95.14M$82.26M(m)$46.01M$24.02M
2024-12-31$351.41M(m)$111.42M$144.27M(m)$64.32M$880.00K
2023-12-31$442.74M(m)$1.10B$158.31M(m)$83.49M-$1.03B
2022-12-31$410.60M(m)$44.27M$115.99M(m)$77.36M$175.06M
2021-12-31$413.75M(m)$70.41M$111.13M(m)-$327.79M$528.45M
2020-12-31$389.52M$3.14M$88.06M$140.00M(m)$2.69M$106.18M
2019-12-31$428.41M$23.88M$115.04M$172.45M(m)$0.00$21.50M
2018-12-31$346.64M$32.75M$101.06M$219.68M(m)$0.00-$282.37M
2017-12-31$298.28M$19.10M$88.14M$231.18M(m)$0.00-$116.94M
2016-12-31$273.96M$1.87M$139.49M$173.28M(m)$0.00-$81.71M
2015-12-31$149.56M$12.00K$108.75M$125.25M(m)$0.00-$142.67M
2014-12-31$76.44M$5.29M$101.89M$118.33M(m)$0.00(m)
2013-12-31$22.88M$7.20M$102.38M$123.23M(m)(m)(m)
2012-12-31$150.25M$965.00K$113.47M$92.54M(m)(m)(m)
2011-12-31$65.87M(m)$86.09M$45.92M$132.01M$3.00K(m)
2010-12-31$43.86M(m)$77.45M$27.17M$104.62M-$2.94M(m)
2009-12-31$34.32M(m)$76.10M(m)$95.14M-$296.00K(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
Verastem, Inc. (VSTM)United States$0.706B-1.71
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Faeth Therapeutics, Inc. (FTH)United States$0.750B
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
Neurogene Inc. (NGNE)$0.625B-4.46
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78